Medicina · Nov 18, 2026

Comparison of Retinopathy Screening Performed Using Conventional Methods and an Artificial Intelligence-Assisted System in Prediabetic and Diabetic Patients: A Single-Center Prospective Analysis

By Arici FN, Sumbul HE, Ozturk HA et al.

Background and Objectives: AI-assisted retinal imaging is increasingly proposed to expand diabetic retinopathy (DR) screening capacity, but most validation studies use reading-center standards, exclude prediabetes, and assess macular edema against photographic surrogates rather than optical coherence tomography (OCT). We compared an AI-assisted retinal screening system with routine ophthalmological examination in an unselected internal medicine screening population. Materials and Methods: In this prospective, cross-sectional diagnostic accuracy study, consecutive adults with prediabetes or diabetes underwent AI-assisted retinal imaging (index test) followed by masked ophthalmological examination (reference standard), with OCT as the reference for macular edema. Analyses were performed at the eye level (n = 714) and patient level (n = 357) using Wilson score 95% confidence intervals and Cohen kappa (κ) for agreement. Results: Among 357 patients (714 eyes; 83.8% diabetes, 16.2% prediabetes), DR prevalence by ophthalmological examination was 15.0% (eyes) and 17.9% (patients), versus 24.4% and 33.1% by AI (McNemar p < 0.001). Eye-level and patient-level sensitivity and specificity were 70.1% and 83.7% and 75.0% and 76.1%, respectively. Negative predictive value was high (93–94%) but positive predictive value was low (41–43%); agreement was moderate at the eye level and fair at the patient level (κ = 0.428 and 0.384, respectively). False-positive AI calls were associated with higher HbA1c and albuminuria (adjusted odds ratio for log-transformed ACR 1.23, p = 0.040); false negatives had milder disease. In prediabetes, DR prevalence was 1.7% and agreement was absent (κ = −0.03). AI sensitivity for OCT-defined macular edema was 45.5% (κ = 0.197), with no significant central macular thickness difference by AI status. Conclusions: The AI system showed high negative predictive value but systematically over-called DR, with only fair-to-moderate agreement and performance below accepted screening benchmarks, particularly in prediabetes and for macular edema. These findings support its use as a rule-out triage adjunct with ophthalmological confirmation of positive results, rather than an autonomous substitute, and argue for local recalibration before deployment.

doi.org/10.3390/medicina62112267Open accessBiomarkers

AgingResearch.News